BBTX

Bambusa Therapeutics, Inc. (BBTX)

Healthcare • NASDAQ • $15.98-0.68%

Key Fundamentals
Symbol
BBTX
Exchange
NASDAQ
Sector
Healthcare
Industry
Biotechnology
Price
$15.98
Daily Change
-0.68%
Market Cap
$819.66M
Trailing P/E
N/A
Forward P/E
N/A
52W High
$17.65
52W Low
$13.60
Analyst Target
N/A
Dividend Yield
0.00%
Beta
N/A
About Bambusa Therapeutics, Inc.

Bambusa Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops long-acting bispecific antibodies for the treatment of immunological and inflammatory disorders. The company develops BBT001 for Type 2 inflammatory dermatological conditions, including atopic dermatitis, chronic spontaneous urticaria, and prurigo nodularis. It also develops BBT002, a long-acting bispecific antibody for respiratory and other Type 2 inflammatory diseases. Additionally, the company develops BBT003, a long-acting bispecific antibody for inflammatory bowel disease, including ulcerative colitis and Crohn's disease. The company also develops BBT004 for depletion of pathogenic B cells and antibody-producing plasma cells in autoantibody-driven autoimmune diseases. The company operates in the United St…

Company website

Research BBTX on Stk-Ai

Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.

Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.

Not financial advice. Pricing · Terms · Privacy · ·

Loading...